Page last updated: 2024-10-29

iohexol and Angiolymphoid Hyperplasia with Eosinophilia

iohexol has been researched along with Angiolymphoid Hyperplasia with Eosinophilia in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Angiolymphoid Hyperplasia with Eosinophilia: Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, R1
Ban, XH1
Mo, YX1
Lv, MM1
Duan, XH1
Shen, J1
Li, JP1
Liu, XW1
Xie, CM1

Other Studies

1 other study available for iohexol and Angiolymphoid Hyperplasia with Eosinophilia

ArticleYear
Kimura's disease: the CT and MRI characteristics in fifteen cases.
    European journal of radiology, 2011, Volume: 80, Issue:2

    Topics: Adolescent; Adult; Aged; Angiolymphoid Hyperplasia with Eosinophilia; Child; Contrast Media; Female;

2011